论文部分内容阅读
目的研究胺碘酮联合氯吡格雷对频发室性早博冠心病患者的预后效果分析。方法选取2013年1月~2015年1月在我院接受治疗的频发室性早搏冠心病患者140例作为研究对象,经我院医学伦理委员会批准后,将患者随机分为观察组与对照组,各70例。其中对照组仅适用胺碘酮进行治疗,观察组在此基础上联合应用氯吡格雷进行治疗,观察两组患者的治疗效果。结果对比两组患者临床症状改善情况、心率失常改善情况以及心电图改善情况,结果观察组有效率明显比对照组高,差异有统计学意义(P<0.05);对比两组患者治疗前后血黏度情况,结果两组患者差异无统计学意义(P>0.05)。结论胺碘酮与氯吡格雷在对频发室性早搏冠心病患者的治疗上有着相互协调的作用,能够显著改善患者的临床症状,值得推广应用。
Objective To study the prognosis of amiodarone combined with clopidogrel in patients with frequent ventricular arrhythmias. Methods From January 2013 to January 2015 in our hospital for treatment of frequent ventricular premature beats in patients with coronary heart disease 140 cases as the research object, approved by the hospital medical ethics committee, the patients were randomly divided into observation group and control group , 70 cases in each. The control group was only treated with amiodarone. The observation group was treated with clopidogrel on the basis of this observation group, and the therapeutic effect was observed in both groups. Results The improvement of clinical symptoms, improvement of arrhythmia and electrocardiogram were compared between the two groups. The results showed that the effective rate of the observation group was significantly higher than that of the control group (P <0.05). The blood viscosity of the two groups before and after treatment Results showed no significant difference between the two groups (P> 0.05). Conclusions Amiodarone and clopidogrel play a coordinating role in the treatment of patients with frequent ventricular premature beats and coronary heart disease, which can significantly improve the clinical symptoms of patients and should be popularized and applied.